See more : Itamar Medical Ltd. (ITMR) Income Statement Analysis – Financial Results
Complete financial analysis of Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nang Kuang Pharmaceutical Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- NightDragon Acquisition Corp. (NDACW) Income Statement Analysis – Financial Results
- T&G Global Limited (TGG.NZ) Income Statement Analysis – Financial Results
- Winto Group (Holdings) Limited (8238.HK) Income Statement Analysis – Financial Results
- Integrated Ventures, Inc. (INTV) Income Statement Analysis – Financial Results
- Reservoir Media, Inc. (RSVR) Income Statement Analysis – Financial Results
Nang Kuang Pharmaceutical Co., Ltd. (1752.TW)
About Nang Kuang Pharmaceutical Co., Ltd.
Nang Kuang Pharmaceutical Co., Ltd. operates as a pharmaceutical company primarily in Taiwan. The company provides parenterals, aseptic parenterals, lyophilized injections, pre-filled syringes, and pre-mixed IV infusion bags, as well as tablets, capsules, topical products, and oral suspensions. It offers various products in the areas of cardiovascular system, gastrointestinal system, nervous system, alimentary and metabolism, blood, antineoplastic and immunomodulatory, musculo-skeletal system, respiratory system, dermatological, genito-urinary and sex hormone, systemic hormone, systemic antibacterial, and cosmetics, as well as hospital solution. In addition, the company offers sterile, anticancer injectable, injectable controlled and oral controlled products, and oral disintegration tablets. Nang Kuang Pharmaceutical Co., Ltd. was founded in 1963 and is headquartered in Tainan City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.15B | 1.94B | 1.78B | 1.75B | 1.76B | 1.54B | 1.50B | 1.55B | 1.52B | 1.28B | 1.01B | 952.14M | 813.12M | 652.83M | 670.03M |
| Cost of Revenue | 1.39B | 1.25B | 1.19B | 1.16B | 1.14B | 1.04B | 987.38M | 974.00M | 971.00M | 867.27M | 716.40M | 624.12M | 561.83M | 449.26M | 432.71M |
| Gross Profit | 755.56M | 694.90M | 594.47M | 596.76M | 622.31M | 499.52M | 516.35M | 575.71M | 549.33M | 409.51M | 296.52M | 328.02M | 251.30M | 203.57M | 237.32M |
| Gross Profit Ratio | 35.14% | 35.81% | 33.40% | 34.01% | 35.31% | 32.47% | 34.34% | 37.15% | 36.13% | 32.07% | 29.27% | 34.45% | 30.91% | 31.18% | 35.42% |
| Research & Development | 164.11M | 143.81M | 133.97M | 159.80M | 130.77M | 154.68M | 135.84M | 116.40M | 106.28M | 114.44M | 103.95M | 73.31M | 80.28M | 55.74M | 44.99M |
| General & Administrative | 106.79M | 95.81M | 88.71M | 86.29M | 112.02M | 86.37M | 82.46M | 84.67M | 81.09M | 68.82M | 66.42M | 61.97M | 55.27M | 63.30M | 63.99M |
| Selling & Marketing | 145.99M | 131.48M | 115.35M | 125.45M | 131.54M | 130.82M | 137.03M | 144.86M | 150.95M | 134.55M | 126.60M | 108.24M | 96.77M | 102.94M | 113.48M |
| SG&A | 331.61M | 227.29M | 204.05M | 211.74M | 243.56M | 217.20M | 219.49M | 229.53M | 232.04M | 203.37M | 193.02M | 170.21M | 152.04M | 166.24M | 177.47M |
| Other Expenses | 0.00 | 91.17M | -26.15M | 1.04M | 8.13M | -4.57M | 60.77M | 46.37M | 25.14M | -675.00K | 16.23M | 21.06M | 10.24M | 8.35M | 2.91M |
| Operating Expenses | 495.65M | 371.09M | 338.02M | 371.54M | 374.33M | 371.88M | 355.32M | 345.93M | 338.32M | 317.81M | 296.97M | 243.52M | 232.32M | 221.98M | 222.45M |
| Cost & Expenses | 1.89B | 1.62B | 1.52B | 1.53B | 1.51B | 1.41B | 1.34B | 1.32B | 1.31B | 1.19B | 1.01B | 867.64M | 794.15M | 671.24M | 655.16M |
| Interest Income | 10.64M | 2.69M | 3.46M | 4.21M | 3.41M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 53.00K | 576.00K | 165.00K | 281.00K |
| Interest Expense | 7.18M | 4.84M | 3.53M | 4.31M | 3.47M | 4.49M | 4.13M | 5.94M | 9.52M | 8.43M | 10.08M | 15.46M | 13.92M | 10.93M | 5.39M |
| Depreciation & Amortization | 181.96M | 176.10M | 179.54M | 185.07M | 192.71M | 196.08M | 177.99M | 171.56M | 163.98M | 152.58M | 121.17M | 106.92M | 99.23M | 84.95M | 69.25M |
| EBITDA | 402.70M | 591.57M | 417.83M | 412.99M | 447.01M | 318.31M | 339.54M | 447.71M | 378.00M | 244.28M | 136.95M | 219.73M | 123.97M | 76.65M | 92.24M |
| EBITDA Ratio | 18.73% | 30.61% | 23.23% | 23.69% | 25.48% | 20.75% | 26.59% | 28.90% | 26.32% | 19.08% | 13.52% | 22.05% | 16.18% | 11.77% | 13.22% |
| Operating Income | 259.91M | 417.67M | 233.76M | 230.47M | 256.11M | 123.07M | 221.80M | 276.15M | 236.15M | 91.03M | 15.78M | 103.01M | 32.30M | -8.12M | 19.33M |
| Operating Income Ratio | 12.09% | 21.52% | 13.13% | 13.13% | 14.53% | 8.00% | 14.75% | 17.82% | 15.53% | 7.13% | 1.56% | 10.82% | 3.97% | -1.24% | 2.88% |
| Total Other Income/Expenses | -46.23M | -7.05M | 1.00M | -6.86M | -5.28M | -5.33M | 56.64M | 40.42M | 15.62M | -9.11M | 6.15M | -9.46M | -8.15M | -825.00K | 2.73M |
| Income Before Tax | 213.68M | 410.63M | 234.76M | 223.61M | 250.82M | 117.74M | 217.67M | 270.21M | 226.63M | 82.60M | 5.70M | 93.56M | 10.82M | -19.24M | 17.60M |
| Income Before Tax Ratio | 9.94% | 21.16% | 13.19% | 12.74% | 14.23% | 7.65% | 14.48% | 17.44% | 14.91% | 6.47% | 0.56% | 9.83% | 1.33% | -2.95% | 2.63% |
| Income Tax Expense | 15.27M | 58.63M | 38.65M | 40.21M | 33.38M | 16.51M | 31.85M | 44.71M | 27.64M | 15.31M | 13.52M | 13.18M | 4.66M | -8.65M | 5.66M |
| Net Income | 198.41M | 352.00M | 196.11M | 183.40M | 217.44M | 101.23M | 185.82M | 225.50M | 198.99M | 67.28M | -7.82M | 80.37M | 6.16M | -10.59M | 11.94M |
| Net Income Ratio | 9.23% | 18.14% | 11.02% | 10.45% | 12.34% | 6.58% | 12.36% | 14.55% | 13.09% | 5.27% | -0.77% | 8.44% | 0.76% | -1.62% | 1.78% |
| EPS | 1.96 | 3.49 | 1.94 | 1.82 | 2.17 | 1.00 | 1.84 | 2.25 | 2.17 | 0.76 | -0.09 | 1.22 | 0.10 | -0.17 | 0.20 |
| EPS Diluted | 1.96 | 3.48 | 1.94 | 1.81 | 2.17 | 1.00 | 1.84 | 2.23 | 1.98 | 0.68 | -0.09 | 1.13 | 0.10 | -0.17 | 0.20 |
| Weighted Avg Shares Out | 100.99M | 100.99M | 100.99M | 100.99M | 100.16M | 100.93M | 100.99M | 100.35M | 91.57M | 89.09M | 85.50M | 66.18M | 63.00M | 63.00M | 58.52M |
| Weighted Avg Shares Out (Dil) | 101.15M | 101.23M | 101.23M | 101.20M | 100.38M | 101.09M | 101.22M | 101.02M | 100.99M | 100.97M | 85.50M | 74.66M | 63.01M | 63.00M | 58.53M |
Source: https://incomestatements.info
Category: Stock Reports